Glycans in Diseases and Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a mechanism employed by cells of the immune system via sugar-binding proteins called lectins, which recognize specific carbohydrate moieties. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology and/or glycochemistry approach to be used.

  • Congenital disorders of glycosylation (CDG)
  • Cardiovascular diseases
  • Cancer biomarkers
  • Cancer associated coagulopathies
  • Transfusion medicine
  • Cardiac arrest
  • Glycomedicine

Related Conference of Glycans in Diseases and Therapeutics

July 13-14, 2018

13th International Conference on Structural Biology

Toronto | Ontario | Canada
August 16-17, 2018

5th Annual Congress on Plant & Soil Science

London, UK
August 27-28, 2018

5th International Conference on Glycobiology, Lipids & Proteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Biophysics

Los Angeles, California, USA
Nov 19-20, 2018

15th World Congress on Structural Biology

Lisbon, Portugal
December 05-06, 2018

4th International Conference on Genetic and Protein Engineering

Chicago, Illinois, USA

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in